Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126597501 | 12659750 | 1 | I | 20160809 | 20151104 | 20160817 | 20160817 | EXP | PHHY2015CO146042 | NOVARTIS | 32.14 | YR | F | Y | 61.00000 | KG | 20160817 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126597501 | 12659750 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, QID (FOUR TIMES A DAY) | 22068 | 200 | MG | CAPSULE | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126597501 | 12659750 | 1 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126597501 | 12659750 | Abdominal pain upper | |
| 126597501 | 12659750 | Feeling abnormal | |
| 126597501 | 12659750 | Headache | |
| 126597501 | 12659750 | Incorrect drug administration duration | |
| 126597501 | 12659750 | Nausea | |
| 126597501 | 12659750 | Oropharyngeal pain | |
| 126597501 | 12659750 | Tonsillar inflammation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126597501 | 12659750 | 1 | 20151023 | 0 |